Videos

How can you increase sensitivity and confidence in working with a patient who has a different cultural background?

A new combination of subjective and objective measures might finally provide a reliable answer.

More than 3.5 million Americans have Autism Spectrum Disorder. How can you recognize the signs in children?

Racism might be hidden where you least expect it...

Recent data from the CDC shows a rise in suicide attempts in girls aged 12-17. What can psychiatrists do?

For students with mental health diagnoses, this program can help with enrolling or re-enrolling in college.

This week, let's focus on the positive.

How can you help patients change what and how they're thinking or behaving if they are feeling ambivalent or conflicted about treatment?

During National Men’s Health Month, take time to consider the unique mental health needs of male patients.

In this custom video series, Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, shares advice that can be helpful to community providers who manage children and adult patients prescribed antipsychotic therapy about screening for involuntary body movements and early signs of tardive dyskinesia.

In this custom video series, recommendations regarding patient selection and use of VMAT2 inhibitors in patients with tardive dyskinesia based on current clinical guidelines and real-world practice are shared.

In this custom video series, key opinion leaders compare VMAT2 inhibitors available for use to treat patients with tardive dyskinesia.

In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, caution against the use of anticholinergic medications for Parkinson’s disease and comment on the use of alternative therapies for appropriate patients.

In this custom video series, experts provide insight into strategies that may be helpful to healthcare professionals who manage patients on antipsychotic therapy to best monitor for signs of tardive dyskinesia, with special considerations regarding telepsychiatry.

In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, reference the Abnormal Involuntary Movement Scale (AIMS) rating scale, used to assess the severity of involuntary movements and help diagnose tardive dyskinesia.

In this custom video series, key opinion leaders discuss what to know about the use of antipsychotic therapy and screening for signs of tardive dyskinesia, and starting treatment with a VMAT2 inhibitor.

Patients with intellectual or developmental disabilities need psychiatrists to learn some special skills.

In this custom video series, experts share overall impressions of a female patient with bipolar 1 disorder who develops new onset movements suggesting tardive dyskinesia and the rationale for intervening with VMAT2 therapy.

In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, review the case of a male patient with schizophrenia who develops symptoms of tardive dyskinesia and comments on the appropriateness for intervening with VMAT2 inhibitor therapy.

Are you having the conversation about food with your patients?

How are events from last week tied together?

Is unresolved trauma the number one problem on planet earth? An economist with expertise in disaster-related distress makes the case.

According to the Dalai Lama, physical care is not enough to achieve wellness.

June 21 is International Yoga Day!

A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.

You must take care of yourself before you can take care of others.

For patients looking to supercharge their memory, what foods are best?

Health outcomes are often determined by factors outside of the hospital and clinic. How can psychiatrists address mental health challenges before they become emergencies?

One doctor travels around the world, building his mask collection.

The FDA approval of aducanumab has given hope to millions of patients with Alzheimer disease—but will it live up to the hype?